Risk of Hematologic Malignancies in Patients With Acute Myocardial Infarction
Authors:
Open Access
- 27 May 2025
- journal article
- Published by Elsevier in JACC: Cardiooncology
- Vol. 7 (5) , 580-589
Abstract
No abstract availableKeywords
Funding Information
- Korean Society of Cardiology
- Soonchunhyang University
This publication has 39 references indexed in Scilit:
- Population health outcomes in South Korea 1990–2019, and projections up to 2040: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Public Health, 2023
- Risk of Cancer After Diagnosis of Cardiovascular DiseaseJACC: Cardiooncology, 2023
- Risk of cancer after ST-segment-elevation myocardial infarctionEuropean Journal of Epidemiology, 2023
- Cardiovascular Disease in Myeloproliferative NeoplasmsJACC: Cardiooncology, 2022
- Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarctionEBioMedicine, 2022
- Cardiovascular Risk Factors Are Associated With Future CancerJACC: Cardiooncology, 2021
- Association between diabetes and haematological malignancies: a population-based studyDiabetologia, 2021
- Myocardial infarction and future risk of cancer in the general population—the Tromsø StudyEuropean Journal of Epidemiology, 2017
- Dysregulation of TET2 in hematologic malignanciesInternational Journal of Hematology, 2016
- Tendencias en mortalidad por infarto de miocardio. Estudio comparativo entre España y Estados Unidos: 1990-2006Revista Española de Cardiología (English Edition), 2012